编码诺如病毒VP1的mRNA在体外产生抗原功能性病毒样颗粒
本研究利用多种人类细胞系(包括THP-1来源的巨噬细胞样细胞)模拟疫苗接种后环境,转染诺如病毒GII.4 VP1 mRNA或脂质纳米颗粒配方的VP1 mRNA,诱导胞内和胞外VP1表达。蔗糖梯度纯化和电镜证实病毒样颗粒(VLP)组装,这些颗粒保留关键抗原和功能特性,包括被人血清中诺如病毒特异性抗体识别及结合组织血型抗原。
要点
- VP1 mRNA可在人细胞中表达并组装成VLP
- VLP保留抗原性和组织血型抗原结合功能
- 结果为mRNA诺如病毒疫苗提供机制依据
核心结论
- 编码VP1的mRNA能在生理相关人细胞系统中产生结构和功能相关的诺如病毒VLP,强化mRNA疫苗机制合理性。
研究设计与样本
- 使用多种人类细胞系(包括THP-1来源巨噬细胞样细胞)模拟疫苗接种后环境,转染诺如病毒GII.4 VP1 mRNA或脂质纳米颗粒配方VP1 mRNA。
主要发现
- 转染诱导胞内和胞外VP1表达。
- 蔗糖梯度纯化和电镜确认VLP组装。
- 颗粒被人血清中诺如病毒特异性抗体识别。
- 颗粒保留结合组织血型抗原的功能特性。
临床怎么用
- 为mRNA诺如病毒疫苗的持续开发提供机制支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human norovirus is a leading cause of acute gastroenteritis worldwide across all age groups, yet no licensed vaccine is available. The major capsid protein, VP1, self-assembles into highly immunogenic virus-like particles (VLPs) that have shown promise in clinical studies. Recently, mRNA has emerged as a compelling platform for norovirus vaccination. However, whether VP1-encoding mRNA can drive authentic VLP formation in human cells relevant to the vaccination environment has remained unknown. In this study, we used multiple human cell lines, including THP-1-derived macrophage-like cells, to model the post-vaccination environment. Transfection with norovirus GII.4 VP1 mRNA or lipid nanoparticle-formulated VP1 mRNA induced both intracellular and extracellular VP1 expression. Sucrose gradient purification and electron microscopy confirmed VLP assembly. These particles retained key antigenic and functional properties, including recognition by norovirus-specific antibodies in human serum and binding to histo-blood group antigens. Collectively, our findings provide direct evidence that VP1-encoding mRNA can generate structurally and functionally relevant norovirus VLPs in physiologically relevant human cell systems. These results strengthen the mechanistic rationale for mRNA-based norovirus vaccines and support their continued development.
引用
- Reyes Ballista JM, David C, Pirrone A, et al. mRNA encoding norovirus VP1 produces antigenically functional virus-like particles in vitro. Vaccine. 2026. PMID: 42933242. doi:10.1016/j.vaccine.2026.129272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。